SCHEMBL15224231

SCHEMBL15224231

NC(=O)CCC(=O)N1CCC2CCCCC2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.45
F2 P00734 1/20 0.39
PLG P00747 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
ST14 Q9Y5Y6 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GNAI3 P08754 5/20 0.38
GNAO1 P09471 5/20 0.38
GNAI1 P63096 5/20 0.38
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.36
SMYD3 Q9H7B4 1/20 0.36
CNR2 P34972 4/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL771655 0.91 HSD11B1 (0.51) HSD11B1ALDH1A1GNAI3GNAO1GNAI1
SCHEMBL15224201 0.86 HSD11B1 (0.47) HSD11B1F2PLGPRSS1PRSS2
SCHEMBL770695 0.85 HSD11B1 (0.46) HSD11B1GNAI3GNAO1GNAI1MEN1
SCHEMBL770743 0.85 SMYD3 (0.48) HSD11B1F2PLGPRSS1PRSS2
SCHEMBL771899 0.85 ATM (0.47) HSD11B1ALDH1A1GNAI3GNAO1GNAI1
SCHEMBL769788 0.84 NPC1 (0.52) HSD11B1GNAI3GNAO1GNAI1MEN1
SCHEMBL770400 0.84 GNAI3 (0.51) HSD11B1ALDH1A1GNAI3GNAO1GNAI1
SCHEMBL769772 0.83 HSD11B1 (0.47) HSD11B1ALDH1A1GNAI3GNAO1GNAI1
SCHEMBL770938 0.82 NPC1 (0.59) HSD11B1ALDH1A1GNAI3GNAO1GNAI1
SCHEMBL771397 0.82 HSD11B1 (0.44) HSD11B1GNAI3GNAO1GNAI1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885F2 3420/4885PLG 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.